BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35287626)

  • 21. Outcomes of intermediate-risk to high-risk stage I endometrial cancer: 10-year clinical experiences of using in-house multi-channel applicators in a single center.
    Hou XR; Yu L; Hu K; Zhang FQ
    Chin Med J (Engl); 2019 Aug; 132(16):1935-1941. PubMed ID: 31365429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective Analysis of All Types of Adjuvant Radiotherapy in Endometrial Cancer: Single-Center Experiences in a Middle-Income Country.
    Chitapanarux N; Tharavichitkul E; Kittidachanan K; Muangwong P; Chakrabandhu S; Klunklin P; Onchan W; Jia-Mahasap B; Torapichattrakul P; Chitapanarux I
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):485-494. PubMed ID: 38415534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External-beam radiotherapy and/or HDR brachytherapy in postoperative endometrial cancer patients: clinical outcomes and toxicity rates.
    De Sanctis V; Agolli L; Valeriani M; Narici S; Osti MF; Patacchiola F; Mossa B; Moscarini M; Maurizi Enrici R
    Radiol Med; 2013 Mar; 118(2):311-22. PubMed ID: 22580814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes in international federation of gynecology and obstetrics stage IA endometrial cancer with myometrial invasion treated with or without postoperative vaginal brachytherapy.
    Diavolitsis V; Rademaker A; Lurain J; Hoekstra A; Strauss J; Small W
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):415-9. PubMed ID: 22365625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.
    Nagar H; Yan W; Parashar B; Nori D; Chao KS; Christos P; Gupta D; Holcomb K; Caputo T; Wernicke AG
    Am J Clin Oncol; 2016 Aug; 39(4):335-9. PubMed ID: 27028349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival of women with clear cell and papillary serous endometrial cancer after adjuvant radiotherapy.
    Foerster R; Kluck R; Rief H; Rieken S; Debus J; Lindel K
    Radiat Oncol; 2014 Jun; 9():141. PubMed ID: 24941899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival rate of early stage endometrioid adenocarcinoma of endometrium treated at Srinagarind Hospital.
    Krusun S; Pesee M; Rasio W; Tangvoraphonkchai V; Supaadirek C; Thamronganantasakul K; Supakalin N; Padoongcharoen P
    Asian Pac J Cancer Prev; 2014; 15(5):2217-20. PubMed ID: 24716960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer.
    Jin M; Hou X; Sun X; Zhang Y; Hu K; Zhang F
    Int J Gynecol Cancer; 2019 Oct; 29(8):1264-1270. PubMed ID: 31320487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporation of vaginal brachytherapy to external beam radiotherapy in adjuvant therapy for high-risk early-stage cervical cancer: A comparative study.
    Ragab OM; Mehta S; Nusbaum DJ; Shimada M; Brunette LL; Roman LD; Matsuo K
    Brachytherapy; 2022; 21(2):141-150. PubMed ID: 34756697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer.
    Horeweg N; Nout RA; Jürgenliemk-Schulz IM; Lutgens LCHW; Jobsen JJ; Haverkort MAD; Mens JWM; Slot A; Wortman BG; de Boer SM; Stelloo E; Verhoeven-Adema KW; Putter H; Smit VTHBM; Bosse T; Creutzberg CL;
    J Clin Oncol; 2023 Sep; 41(27):4369-4380. PubMed ID: 37487144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis.
    Kong A; Johnson N; Kitchener HC; Lawrie TA
    J Natl Cancer Inst; 2012 Nov; 104(21):1625-34. PubMed ID: 22962693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Prognostic Factors and Adjuvant Radiotherapy on Survival in Patients with High-Grade Early-Stage Endometrial Cancer: A Retrospective Clinical Study.
    Yilmaz E; Gurocak S; Melekoglu R; Koleli I; Faydali S; Temelli O; Yar T
    Med Sci Monit; 2019 Apr; 25():2811-2818. PubMed ID: 30992424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.
    Harkenrider MM; Block AM; Alektiar KM; Gaffney DK; Jones E; Klopp A; Viswanathan AN; Small W
    Brachytherapy; 2017; 16(1):95-108. PubMed ID: 27260082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?
    Backes FJ; Felix AS; Plante M; Grégoire J; Sullivan SA; Rossi EC; Tanner EJ; Stewart KI; Soliman PT; Holloway RW; Abu-Rustum NR; Leitao MM
    Gynecol Oncol; 2021 May; 161(2):347-352. PubMed ID: 33678480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma.
    Yoon MS; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Lee KK; Kim M; Jeong JU; Chang SK; Park W
    Cancer Res Treat; 2016 Jul; 48(3):1074-83. PubMed ID: 26511800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization Trend and Comparison of Different Radiotherapy Modes for Patients with Early-Stage High-Intermediate-Risk Endometrial Cancer: A Real-World, Multi-Institutional Study.
    Ren K; Zou L; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Sun S; Wang W; Hu K; Zhang F; Hou X; Wei L
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Outcome of Exclusively Radiographer-led Delivery of Postoperative Vaginal Vault Brachytherapy for Endometrial Cancer - The Addenbrooke's Experience.
    Buckley H; Bradshaw K; Gregory D; Prewett S; Tan LT
    Clin Oncol (R Coll Radiol); 2019 Dec; 31(12):844-849. PubMed ID: 31307862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncological Outcomes of Stage II Endometrial Cancer: A Retrospective Analysis of 250 Cases.
    Ozgul N; Boyraz G; Salman MC; Gultekin M; Yuce K; Ibrahimov A; Erturk A; Gungorduk K; Gulseren V; Sanci M; Turkmen O; Karalok A; Kimyon G; Turan T; Ozkan NT; Meydanli MM; Gungor T; Ayik H; Simsek T
    Int J Gynecol Cancer; 2018 Jan; 28(1):161-167. PubMed ID: 28930810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant vaginal brachytherapy and chemotherapy versus pelvic radiotherapy in early-stage endometrial cancer: Outcomes by risk factors.
    Tatebe K; Hasan Y; Son CH
    Gynecol Oncol; 2019 Dec; 155(3):429-435. PubMed ID: 31610885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved overall survival with adjuvant radiotherapy for high-intermediate and high risk Stage I endometrial cancer.
    Harkenrider MM; Adams W; Block AM; Kliethermes S; Small W; Grover S
    Radiother Oncol; 2017 Mar; 122(3):452-457. PubMed ID: 28012794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.